Sagimet Biosciences
SGMT
SGMT
81 hedge funds and large institutions have $122M invested in Sagimet Biosciences in 2024 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 31 increasing their positions, 11 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
38.13% more ownership
Funds ownership: 67.62% → 105.75% (+38%)
Holders
81
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$14.5M | |
| 2 | +$8.88M | |
| 3 | +$7.15M | |
| 4 |
JPMorgan Chase & Co
New York
|
+$6.07M |
| 5 |
RI
RTW Investments
New York
|
+$5.42M |
Top Sellers
| 1 | -$10M | |
| 2 | -$9.71M | |
| 3 | -$3.93M | |
| 4 |
ACM
Altium Capital Management
New York
|
-$2.53M |
| 5 |
AG
Artal Group
Luxembourg
|
-$1.08M |